Related Experiment Video
Updated: Sep 16, 2025

06:40
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
1.4K
Pharmacy cost groups for the German morbidity-based risk compensation scheme
Christian J A Schindler1, Benjamin Berndt2, Dennis Häckl2,3
1WIG2 Scientific Institute for Health Economics and Health System Research, Leipzig, Germany. christian.schindler@wig2.de.
Summary
Germany
Area of Science:
- Health economics
- Healthcare policy
- Medical informatics
Background:
- Germany's statutory health insurance (SHI) uses a diagnosis-based risk adjustment scheme.
- Concerns exist regarding the quality and manipulability of diagnostic coding.
- This study explores pharmaceutical data as an alternative or supplement.
Purpose of the Study:
- To evaluate a pharmacy-based risk adjustment model for German SHI.
- To assess its potential as an extension or alternative to the current diagnosis-based system.
- To analyze its impact on model performance and risk selection.
Main Methods:
- Adapted an existing pharmacy-based model to German conditions.
- Used claims data from approximately 4.5 million insured persons for a representative sample.
- Evaluated models using R², Cumming's Predictive Measure (CPM), and Mean Absolute Prediction Error (MAPE).
Main Results:
- A sample closely matched German SHI data.
- Replacing diagnostic data with pharmacy cost groups (PCGs) yielded comparable model quality but worsened under/overcompensation for vulnerable groups.
- Integrating PCGs into the existing model improved most performance measures.
Conclusions:
- Pharmacy-based models show significant potential for German risk compensation.
- Extending the current system with PCGs enhances statistical performance and morbidity measurement.
- This approach offers a viable strategy to mitigate diagnostic coding manipulation incentives.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
180
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
180
Dosage Regimen: Fixed Dose
2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
Pharmacokinetic Models: Overview
1.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.2K
Model Approaches for Pharmacokinetic Data: Compartment Models
205
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
205
Prescription, Nonprescription and Orphan Drugs
854
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
854

